Net profit of Medicamen Biotech rose 59.26% to Rs 2.15 crore in the quarter ended June 2025 as against Rs 1.35 crore during the previous quarter ended June 2024. Sales declined 0.02% to Rs 43.04 crore in the quarter ended June 2025 as against Rs 43.05 crore during the previous quarter ended June 2024.
| Particulars | Quarter Ended |
| Jun. 2025 | Jun. 2024 | % Var. |
| Sales | 43.04 | 43.05 | 0 |
| OPM % | 10.73 | 7.99 | - |
| PBDT | 3.93 | 3.33 | 18 |
| PBT | 2.13 | 1.56 | 37 |
| NP | 2.15 | 1.35 | 59 |